225 related articles for article (PubMed ID: 28277619)
1. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V
Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619
[TBL] [Abstract][Full Text] [Related]
2. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract][Full Text] [Related]
3. Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer.
Zhou BX; Li Y
Kaohsiung J Med Sci; 2020 May; 36(5):336-343. PubMed ID: 31930774
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes.
Hartlieb E; Rötzer V; Radeva M; Spindler V; Waschke J
J Biol Chem; 2014 Jun; 289(24):17043-53. PubMed ID: 24782306
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.
Ramani VC; Hennings L; Haun RS
BMC Cancer; 2008 Dec; 8():373. PubMed ID: 19091121
[TBL] [Abstract][Full Text] [Related]
6. TROP2 Down-regulated DSG2 to Promote Gastric Cancer Cell Invasion and Migration by EGFR/AKT and DSG2/PG/β-Catenin Pathways.
Yang T; Jia L; Bian S; Chang X; Zhang Q; Tang Q; Zhu J; Yang Z; Feng Z
Curr Cancer Drug Targets; 2022 Aug; 22(8):691-702. PubMed ID: 35392784
[TBL] [Abstract][Full Text] [Related]
7. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2.
Klessner JL; Desai BV; Amargo EV; Getsios S; Green KJ
Mol Biol Cell; 2009 Jan; 20(1):328-37. PubMed ID: 18987342
[TBL] [Abstract][Full Text] [Related]
8. The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery.
Cirillo N; Lanza M; De Rosa A; Cammarota M; La Gatta A; Gombos F; Lanza A
J Cell Biochem; 2008 Feb; 103(2):598-606. PubMed ID: 17559062
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.
Lorch JH; Klessner J; Park JK; Getsios S; Wu YL; Stack MS; Green KJ
J Biol Chem; 2004 Aug; 279(35):37191-200. PubMed ID: 15205458
[TBL] [Abstract][Full Text] [Related]
10. Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury.
Gross A; Pack LAP; Schacht GM; Kant S; Ungewiss H; Meir M; Schlegel N; Preisinger C; Boor P; Guldiken N; Krusche CA; Sellge G; Trautwein C; Waschke J; Heuser A; Leube RE; Strnad P
Mucosal Immunol; 2018 Nov; 11(6):1630-1639. PubMed ID: 30115995
[TBL] [Abstract][Full Text] [Related]
11. Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling.
Kamekura R; Kolegraff KN; Nava P; Hilgarth RS; Feng M; Parkos CA; Nusrat A
Oncogene; 2014 Sep; 33(36):4531-6. PubMed ID: 24166502
[TBL] [Abstract][Full Text] [Related]
12. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
Hartlieb E; Kempf B; Partilla M; Vigh B; Spindler V; Waschke J
PLoS One; 2013; 8(1):e53739. PubMed ID: 23326495
[TBL] [Abstract][Full Text] [Related]
13. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling.
Kolegraff K; Nava P; Helms MN; Parkos CA; Nusrat A
Mol Biol Cell; 2011 Apr; 22(8):1121-34. PubMed ID: 21325624
[TBL] [Abstract][Full Text] [Related]
14. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium.
Nava P; Laukoetter MG; Hopkins AM; Laur O; Gerner-Smidt K; Green KJ; Parkos CA; Nusrat A
Mol Biol Cell; 2007 Nov; 18(11):4565-78. PubMed ID: 17804817
[TBL] [Abstract][Full Text] [Related]
15. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis.
Ebert LM; Tan LY; Johan MZ; Min KK; Cockshell MP; Parham KA; Betterman KL; Szeto P; Boyle S; Silva L; Peng A; Zhang Y; Ruszkiewicz A; Zannettino AC; Gronthos S; Koblar S; Harvey NL; Lopez AF; Shackleton M; Bonder CS
Angiogenesis; 2016 Oct; 19(4):463-86. PubMed ID: 27338829
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer.
Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z
Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602
[TBL] [Abstract][Full Text] [Related]
17. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
[TBL] [Abstract][Full Text] [Related]
18. Plakoglobin but not desmoplakin regulates keratinocyte cohesion via modulation of p38MAPK signaling.
Spindler V; Dehner C; Hübner S; Waschke J
J Invest Dermatol; 2014 Jun; 134(6):1655-1664. PubMed ID: 24441103
[TBL] [Abstract][Full Text] [Related]
19. Desmoglein 2 can undergo Ca
Fuchs M; Kugelmann D; Schlegel N; Vielmuth F; Waschke J
Biophys J; 2022 Apr; 121(7):1322-1335. PubMed ID: 35183520
[TBL] [Abstract][Full Text] [Related]
20. Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
Kant S; Holthöfer B; Magin TM; Krusche CA; Leube RE
Circ Cardiovasc Genet; 2015 Aug; 8(4):553-63. PubMed ID: 26085008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
